Abbreviated Approval Process In the Works for 'Biosimilar' Drugs

Martin Sipkoff

首页> 外文期刊>Managed care >Abbreviated Approval Process In the Works for 'Biosimilar' Drugs

【24h】

Abbreviated Approval Process In the Works for 'Biosimilar' Drugs

机译：“生物仿制药”药品的简化审批流程

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Managed care》 |2007年第4期|共页
作者
Martin Sipkoff;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类文教、卫生管理法令;
关键词

相似文献

外文文献
中文文献
专利

1. FDA Issues Final Rule on Patent Listing Requirements and 30-Month Stays of Approval Following Submission of Abbreviated New Drug Applications -- Changes Will Alter the Playing Field for Big Pharma and Generic Drug Companies [J] . BARRY J. MARENBERG Biotechnology Law Report . 2004,第1期

机译：在提交简短的新药申请后，FDA颁布了关于专利列表要求和30个月的批准中止的最终规则-变化将改变大型制药公司和仿制药公司的竞争环境
2. Understanding the biosimilar approval and extrapolation process-A case study of an epoetin biosimilar [J] . Agarwal Amit B., McBride Ali Critical reviews in oncology/hematology . 2016,第Null期

机译：了解生物仿制药的批准和外推过程-以Epoetin生物仿制药为例
3. First ASEAN educational workshop on regulation and approval of biosimilars/similar biotherapeutic products 2017 – Report [J] . Robin Thorpe, Elwyn Griffiths, Niklas Ekman GaBi journal. . 2018,第3期

机译：2017年首届东盟生物仿制药/类似生物治疗产品监管和批准教育研讨会–报告
4. Investigating the Food and Drug Administration (FDA) Biotherapeutics Review and Approval Process: A Scoping Review [C] . Samuel A. Bonet, Farzan Sasangohar, Mark Lawley Human Factors and Ergonomics Society annual meeting . 2018

机译：调查食品和药物管理局（FDA）生物治疗审查和审批过程：审查审查
5. The constitutional political economy of the new drug approval process: Between reason and success. [D] . Vardon, Peter J. 2003

机译：新药批准程序的宪法政治经济学：在理性与成功之间。
6. Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America [O] . Judith Steinberg, Yara D. Fragoso, Juan Carlos Duran Quiroz, 2019

机译：关于批准和使用生物仿制药治疗拉丁美洲多发性硬化症的实际问题
7. New Approved New approval, indications, formulation; Merck Manual now in 20th edition; first epoetin alfa biosimilar; Drugs@FDA mobile app [O] . 2018

机译：新的和批准的新批准，适应症，配方;默克手册现在在第20版;首先Epoetin Alfa BioSimilar;药物@ FDA移动应用程序

Abbreviated Approval Process In the Works for 'Biosimilar' Drugs

著录项

相似文献

相关主题

期刊订阅